Status:
UNKNOWN
the Effects of YangXinShi (YXS) on the Quality of Life and Exercise Tolerance in Patients With Chronic Heart Failure
Lead Sponsor:
Dalian University
Conditions:
Chronic Heart Failure
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
Brief Summary
The investigators set out to evaluate the effects of the traditional Chinese medicinal mixture under the brand name YangXinShi (YXS) on the prognosis in patients with chronic heart failure when it is ...
Eligibility Criteria
Inclusion
- patients newly diagnosed with heart failure or have been diagnosed with chronic heart failure
- patients classified as NYHA II-IV (New York Heart Association)
Exclusion
- with severe liver or renal dysfunction
- with severe systematic conditions such as infection, malignant hypertension etc.
- hemodynamic instability (arrhythmia, acute cardiac infarction, aortic dissection etc.)
- not cooperating due to psychomotor deficiency, or with contraindications for exercise testing
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03333499
Start Date
November 1 2017
End Date
December 1 2018
Last Update
November 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Cardiology, Affiliated Zhongshan hospital of Dalian University
Dalian, Liaoning, China, 116001